Instrument Inactif

Communiqués Icagen, Inc.

Actions

US45104P5008

Recherche biotechnologique et médicale

Cours en clôture Nasdaq
- ^USD	-

28/06/11	Le point sur les marchés	RE
27/06/11	Wall St termine en nette hausse, rebond des bancaires	RE

Communiqués

21/07/11	ICAGEN IN : Ryan & Maniskas, LLP Announces Investigation of Icagen, Inc.	BU
21/07/11	ICAGEN IN : Murray Frank LLP Investigates Icagen, Inc.	BU
21/07/11	ICAGEN IN : The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of Icagen, Inc.	BU
20/07/11	ICAGEN IN : The Law Firm of Levi & Korsinsky, LLP Announces Investigation of Icagen, Inc.	BU
20/07/11	ICAGEN IN : Finkelstein Thompson LLP Announces Investigation of Icagen, Inc.	BU
20/07/11	ICAGEN IN : Rigrodsky & Long, P.A. Announces Investigation of Icagen, Inc.	BU
20/07/11	ICAGEN IN : Law Office of Brodsky & Smith, LLC Announces Investigation of Icagen, Inc.	BU
20/07/11	ICAGEN IN : Law Firm Brower Piven Announces Investigation of Icagen, Inc.	BU
20/07/11	ICAGEN IN : Tripp Levy PLLC Announces Investigation of Icagen	BU
30/11/-1	ICAGEN : to Report Second Quarter 2008 Results and Conduct Conference Call on August 5, 2008	PR
30/11/-1	Icagen : Icagen Scientists to Be Featured at Upcoming Industry Forums	BU
30/11/-1	Icagen : Icagen to Present at the UBS Global Life Sciences Conference	BU
30/11/-1	Icagen : Icagen Announces Initiation of Phase I Study of ICA-105665, a Novel Compound for the Treatment of Epilepsy	BU
30/11/-1	Icagen : Icagen Announces First Closing of Investment by Pfizer	BU
30/11/-1	Icagen : Icagen Announces Investment by Pfizer	BU
30/11/-1	Icagen : Icagen Announces Alliance with Pfizer in Ion Channel-Focused Therapeutics for Pain and Related Disorders	BU
30/11/-1	Icagen : Icagen Reports Second Quarter 2007 Financial Results	BU
30/11/-1	Icagen : Icagen Announces Second Quarter Conference Call	BU
30/11/-1	Icagen : Icagen Announces Filing of Ind for ICA-105665, a Novel Compound for the Treatment of Epilepsy	BU
30/11/-1	Icagen : Icagen to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference	BU
30/11/-1	Icagen : Icagen Receives Notification from McNeil of Termination of Collaboration Agreement	BU
30/11/-1	Icagen : Icagen Announces New Members of Drug Discovery and Development Expert Panel	BU
30/11/-1	Icagen : Icagen Reports First Quarter 2007 Financial Results	BU
30/11/-1	Icagen : Icagen Announces First Quarter Conference Call	BU
30/11/-1	Icagen : Icagen Announces Formation of Drug Discovery and Development Expert Panel	BU